Company / strategic investorRegistered location :Frankfurt, DEGroup :J.P. Morgan Securities plc

J.P. Morgan SEDeclared Swiss shareholdings

J.P. Morgan SE: 0 Swiss companies with a declared holding.

Disclosure tracking · company alerts with Pro
Estimated value (CHF)
—
Swiss companies held
0
Largest position
—
12-month trend
Not determinable
0 rate rises · 0 rate falls
Latest filing
…

Declared Swiss portfolio

Latest declared rate per company

No active declared position.

How to read these figures?

Rates come from the 112 official filings published by SIX Exchange Regulation. A filing is only required when a threshold is crossed (3, 5, 10, 15, 20, 25, 33⅓, 50, 66⅔%): the actual position may have changed since.

Estimated value = shares held per the latest filing × latest CHF closing price. It is an indicative order of magnitude: the position may have changed without a new threshold being crossed, and holdings without a share count or a CHF price are not valued. Each company's mini-chart traces the successive declared rates.

This profile shows only what the declarant published. No external data is added to it.

Group structure

Shareholding disclosures are often filed jointly by several entities of the same group. The registry links them together: "Controls" lists the group entities declared alongside this shareholder, "Controlled by" the head entities. The figure is the number of joint disclosures, followed by the date of the most recent one.

Show group structure1 controlled by

Controlled by

Group entities that file jointly with this shareholder as its head.

This mapping reflects observed disclosures; it does not necessarily indicate permanent legal control.

Disclosure behaviour

Upward and downward threshold crossings show direction, without measuring daily trades below legal thresholds.

90 days · Upward crossings

0

visible history: 0

90 days · Downward crossings

0

visible history: 0

First disclosure: —Last disclosure: —

Latest shareholding disclosures

Show 37 older disclosures
PurchaseShareholdings

Kuros Biosciences AG

J.P. Morgan SE · Single shareholder

5.39%Voting rights acquired30.09.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

7.527%Voting rights acquired26.09.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

11.43%Voting rights acquired23.09.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

10.048%Voting rights acquired23.09.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

7.082%Voting rights acquired23.09.2026
PurchaseShareholdings

Kuros Biosciences AG

J.P. Morgan SE · Single shareholder

5.087%Voting rights acquired18.09.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

12.614%Voting rights acquired18.09.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

13.531%Voting rights acquired16.09.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

14.032%Voting rights acquired16.09.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

14.983%Voting rights acquired02.09.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

15.192%Voting rights acquired02.09.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

15.053%Voting rights acquired29.08.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

15.064%Voting rights acquired29.08.2026
PurchaseShareholdings

Kuros Biosciences AG

J.P. Morgan SE · Single shareholder

7.014%Voting rights acquired27.08.2026
PurchaseShareholdings

Kuros Biosciences AG

J.P. Morgan SE · Single shareholder

4.486%Voting rights acquired27.08.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

12.66%Voting rights acquired23.07.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

13.451%Voting rights acquired23.07.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

13.025%Voting rights acquired18.07.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

13.643%Voting rights acquired18.07.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

13.724%Voting rights acquired18.07.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

11.844%Voting rights acquired12.07.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

12.194%Voting rights acquired12.07.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

11.952%Voting rights acquired12.07.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

12.263%Voting rights acquired08.07.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

12.155%Voting rights acquired26.06.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

12.434%Voting rights acquired19.06.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

11.373%Voting rights acquired11.06.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

9.638%Voting rights acquired08.04.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

9.879%Voting rights acquired28.01.2026
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

11.177%Voting rights acquired02.12.2025
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

11.177%Voting rights acquired26.11.2025
PurchaseShareholdings

Rieter Holding AG

J.P. Morgan SE · Single shareholder

46.779%Voting rights acquired14.10.2025
PurchaseShareholdings

Rieter Holding AG

J.P. Morgan SE · Single shareholder

62.447%Voting rights acquired14.10.2025
PurchaseShareholdings

Rieter Holding AG

J.P. Morgan SE · Single shareholder

51.699%Voting rights acquired07.10.2025
PurchaseShareholdings

Rieter Holding AG

J.P. Morgan SE · Single shareholder

62.447%Voting rights acquired03.10.2025
PurchaseShareholdings

Rieter Holding AG

J.P. Morgan SE · Single shareholder

46.779%Voting rights acquired03.10.2025
PurchaseShareholdings

DocMorris AG

J.P. Morgan SE · Single shareholder

7.398%Voting rights acquired27.09.2025

insider24.ch

Follow J.P. Morgan SE’s disclosures

Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

Common questions

Which Swiss companies are in J.P. Morgan SE’s disclosed portfolio?

No active holding identified in available disclosures.

What is J.P. Morgan SE’s latest disclosure?

The latest available disclosure was published on 29.10.2026 and concerns DocMorris AG. Threshold disclosures do not describe every purchase or sale.

Explore further

Recent insider purchases

What are insiders doing at companies disclosed by this shareholder?

All purchases this week

Insider barometer

Compare insider purchases and sales across the Swiss stock exchange over 30 days.

View the Swiss barometer

These signals are not investment advice.